ScienceDaily: Top News |
| Neoadjuvant immunotherapy prior to surgery is safe, feasible in early lung cancer Posted: 07 Oct 2016 05:46 AM PDT Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers report. |
| You are subscribed to email updates from Latest Science News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
ليست هناك تعليقات:
إرسال تعليق